The Food and Drug Administration (FDA) asked for public input on the safety and efficacy of cannabidiol (CBD) — and more than 100 people used that opportunity to tell the agency that their pets benefit from the cannabis compound.
The volume of pet-related comment submissions stood out to the analysis firm PARC, which sifted through the thousands of submissions FDA received during the three months that the comment period for CBD regulations was open and shared its takeaways with Marijuana Moment.